Iwase Hiroaki, Indo Toshihiko, Shimada Masaaki, Tuzuki Tomoyuki, Nakarai Keiko, Kaida Syogo, Doi Reiko, Okeya Masayuki, Kato Eriko
Dept of Gastroenterology, Nagoya National Hospital.
Gan To Kagaku Ryoho. 2004 Jul;31(7):1075-7.
A 52-year-old man was hospitalized for evaluation of dysphagia. Esophagography depicted an irregular narrowing extending 7 cm from the cervical esophagus to the upper thoracic esophagus. Esophagoscopy with biopsy showed cervical esophageal cancer narrowing the lumen. Surgery was contraindicated because of a previous cardiac infarction. The patient selected concurrent chemoradiotherapy with TS-1 and cisplatin. The first course included 30 Gy of radiotherapy given over 3 weeks, together with daily oral administration of TS-1 (120 mg/day) for 2 weeks, and a 24-h infusion of cisplatin (70 mg/m2) on day 8. After a second course of chemoradiotherapy, 4 courses of chemotherapy with TS-1 and cisplatin were administered at 4-week intervals. After additional chemotherapy, esophagoscopy and cervical CT showed that the primary lesion had disappeared. Two years after initial hospitalization, no recurrence has been detected.
一名52岁男性因吞咽困难入院评估。食管造影显示从颈段食管至胸段食管上段有一段7厘米长的不规则狭窄。食管镜检查及活检显示颈段食管癌致管腔狭窄。因既往有心肌梗死史,手术为禁忌。患者选择了TS-1和顺铂同步放化疗。第一个疗程包括在3周内给予30 Gy放疗,同时连续2周每日口服TS-1(120毫克/天),并在第8天给予顺铂24小时静脉输注(70毫克/平方米)。在第二个放化疗疗程后,每4周进行4个疗程的TS-1和顺铂化疗。追加化疗后,食管镜检查及颈部CT显示原发灶消失。首次住院两年后,未检测到复发。